Emmaus Life Sciences Receives Endari® Marketing Authorization from the Bahrain NHRA
TORRANCE, Calif., May 31, 2023 /PRNewswire/ -- Emmaus Life Sciences, Inc. , a leader in sickle cell disease treatment, announced today that it has received a Medicine Registration... | June 7, 2023